// App-Quantinova.ai

438.0 : Treatment of hepatocellular carcinoma (HCC) after sorafenib (S) over the last 10 years.

Researchers

Presenter

  • Andrea S. Fung

Principal Investigators

  • Richard M. Lee-Ying

  • Daniel E. Meyers

  • Hao-Wen Sim

  • Jennifer J. Knox

  • Valeriya O. Zaborska

  • Janine Marie Davies

  • Yoo-Joung Ko

  • Eugene Batuyong

  • Winson Y. Cheung

  • Haider Samawi

  • Vincent C. Tam

Medical Centers

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • Tom Baker Cancer Center - University of Calgary, Calgary, AB, Canada

  • University of Calgary Tom Baker Cancer Centre, Calgary, AB, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada

  • British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna, BC, Canada

  • Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • BC Cancer Agency, Vancouver, BC, Canada

  • University of Calgary, Calgary, AB, Canada

  • University of Calgary Tom Baker Cancer Centre, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Sorafenib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved